Literature DB >> 1330166

Effect of neuropeptide Y on adrenergic and non-adrenergic, non-cholinergic responses in the rat anococcygeus muscle.

E Vila1, A Tabernero, F Fernandes, M Salaices.   

Abstract

1. The effects of neuropeptide Y (NPY) were examined on adrenergic and non-adrenergic, non-cholinergic (NANC) neurotransmission in the rat anococcygeus muscle. 2. NPY (0.1-0.3 microM) greatly potentiated the contractile responses induced by field stimulation. Prazosin (0.1 microM) completely abolished the stimulation-induced responses either in the absence or presence of NPY. 3. NPY (0.1-0.3 microM) enhanced only the contractile responses to low doses of noradrenaline (NA, 0.003-0.01 microM). Responses to tyramine were unaffected by the same concentrations of NPY. 4. In superfused anococcygeus, previously loaded with [3H]-NA, NPY (0.1-0.3 microM) failed to modify the basal, as well as the stimulation-evoked, release of tritium at 2 and 4 Hz. 5. NANC relaxations induced by electrical stimulation were significantly reduced, in a concentration-related manner, by 0.1-0.3 microM NPY. 6. L-NG-nitro-arginine (L-NOARG, 30 microM) enhanced the stimulation (0.25-1 Hz)-induced motor responses. In the presence of L-NOARG (30 microM), NPY (0.1 microM) did not modify the motor responses induced by field stimulation (0.25-0.5 Hz). L-Arginine did not reverse the NPY-induced potentiation of stimulation-induced motor responses. 7. The relaxations of anococcygeus muscle induced by sodium nitroprusside (SNP, 0.01-0.3 microM) were diminished by NPY (0.1-0.3 microM). 8. Our study suggests that NPY, at concentrations devoid of contractile effect, potentiates the motor responses of rat anococcygeus muscle as a consequence, at least in part, of the inhibition of NANC relaxing responses by a different mechanism from L-NOARG.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330166      PMCID: PMC1907601          DOI: 10.1111/j.1476-5381.1992.tb14464.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

Review 1.  Neuropeptide Y as an autonomic neurotransmitter.

Authors:  E K Potter
Journal:  Pharmacol Ther       Date:  1988       Impact factor: 12.310

2.  The effects of pyrogallol and hydroquinone on the response to NANC nerve stimulation in the rat anococcygeus and the bovine retractor penis muscles.

Authors:  J S Gillespie; H Sheng
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

3.  Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control.

Authors:  J Pernow; A Saria; J M Lundberg
Journal:  Acta Physiol Scand       Date:  1986-02

4.  Neuropeptide Y neuromodulation of sympathetic co-transmission in the guinea-pig vas deferens.

Authors:  J L Ellis; G Burnstock
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

5.  Neuropeptide Y preferentially potentiates responses to adrenergic nerve stimulation by increasing rate of contraction.

Authors:  H Q Vu; D Budai; S P Duckles
Journal:  J Pharmacol Exp Ther       Date:  1989-12       Impact factor: 4.030

6.  Modulation of noradrenaline release from cat cerebral arteries by presynaptic alpha 2-adrenoceptors. Effect of chronic treatment with desipramine and cocaine.

Authors:  G Balfagón; J Marín
Journal:  Gen Pharmacol       Date:  1989

7.  Neuropeptide Y: complete amino acid sequence of the brain peptide.

Authors:  K Tatemoto
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

8.  L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro.

Authors:  P K Moore; O A al-Swayeh; N W Chong; R A Evans; A Gibson
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

9.  Neuropeptide Y induces and modulates vasoconstriction in intracranial and peripheral vessels of animals and man.

Authors:  J H Hanko; K Törnebrandt; J E Hardebo; J Kåhrström; A Nobin; C Owman
Journal:  J Auton Pharmacol       Date:  1986-06

10.  Peptide-containing nerves in the rat femoral artery and vein. An immunocytochemical and vasomotor study.

Authors:  L Edvinsson; S Gulbenkian; J Wharton; I Jansen; J M Polak
Journal:  Blood Vessels       Date:  1989
View more
  5 in total

1.  Receptor recruitment: a mechanism for interactions between G protein-coupled receptors.

Authors:  U Holtbäck; H Brismar; G F DiBona; M Fu; P Greengard; A Aperia
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

2.  Pharmacological characterization of neurogenic responses of the sheep isolated internal anal sphincter.

Authors:  M K Mundey; M Jonas; T Worthley; J H Scholefield; V G Wilson
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

3.  Characterization of the ORL(1) receptor on adrenergic nerves in the rat anococcygeus muscle.

Authors:  M Ho; A D Corbett; A T McKnight
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

4.  Decreased gallbladder response in leptin-deficient obese mice.

Authors:  Matthew I Goldblatt; Deborah A Swartz-Basile; Carol L Svatek; Atilla Nakeeb; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2002 May-Jun       Impact factor: 3.452

5.  Enhanced noradrenergic transmission in the spontaneously hypertensive rat anococcygeus muscle.

Authors:  Francesc Jimenez-Altayo; Jesus Giraldo; John C McGrath; Elisabet Vila
Journal:  Br J Pharmacol       Date:  2003-09-22       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.